AHA Statement on New HRSA Drug Pricing Website

Tom Nickels
Executive Vice President
American Hospital Association

April 1, 2019


The AHA is pleased that, in response to our successful lawsuit, the Health Resources and Services Administration today launched a new website to shine needed light on 340B drug pricing, which the government has found lacking. This website will help make sure hospitals participating in the program are not being overcharged by drug companies and that instances of price gouging can be uncovered and penalties enforced. As prescription drug prices continue to skyrocket, the 340B program is as crucial as ever in helping hospitals provide access to health care services for patients in vulnerable communities.






Marie Johnson, (202) 626-2351 mjohnson@aha.org

aColin Milligan, (202) 638-5491 cmilligan@aha.org

Related Resources

Special Bulletin
Download the Special Bulletin: CMS Releases Proposed Rule on Medicaid Drug Value-based Purchasing Arrangements   The Centers for Medicare &…
Webinar Recordings
A panel of 4 experts discussed federal policy emerging from Congress and the Administration under COVID-19 focusing on rural health priorities and took…
Dear Secretary Azar: On behalf of our nearly 2,000 340B member hospitals, the American Hospital Association (AHA) urges the Department of Health and Human…
The AHA submitted its comments to the Office of Management and Budget regarding the Centers for Medicare & Medicaid Services (CMS) plans to collect pricing…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec lacus justo, scelerisque ut orci vitae, venenatis dignissim sapien. In vitae enim quis purus…